Renal kallistatin overexpression protects against DN by ameliorating oxidative stress, inflammation, and fibrosis, potentially through inhibiting AGE-RAGE axis and microRNA-34a signaling (74, 75). The gene discussed is SERPINA4; the disease is liver dysplastic nodule.